Cohen AF - Search Results

1

Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator.

de Boer A, Kluft C, Kroon JM, Kasper FJ, Schoemaker HC, Pruis J, Breimer DD, Soons PA, Emeis JJ, Cohen AF. de Boer A, et al. Among authors: cohen af. Thromb Haemost. 1992 Jan 23;67(1):83-7. Thromb Haemost. 1992. PMID: 1615490

2

Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.

de Boer A, Kluft C, Dooijewaard G, Kasper FJ, Kroon JM, Breimer DD, Stiekema JC, Cohen AF. de Boer A, et al. Among authors: cohen af. Thromb Haemost. 1992 Nov 10;68(5):550-5. Thromb Haemost. 1992. PMID: 1280862 Clinical Trial.

3

Clearance of plasminogen activator--a major determinant of plasma concentration: therapeutic and diagnostic implications.

Cohen AF, Burggraaf K, de Boer A, Kluft C. Cohen AF, et al. Ann N Y Acad Sci. 1992 Dec 4;667:443-9. doi: 10.1111/j.1749-6632.1992.tb51646.x. Ann N Y Acad Sci. 1992. PMID: 1309067 Review. No abstract available.

4

Highly variable anticoagulant response after subcutaneous administration of high-dose (12,500 IU) heparin in patients with myocardial infarction and healthy volunteers.

Kroon C, ten Hove WR, de Boer A, Kroon JM, van der Pol JM, Harthoorn-Lasthuizen EJ, Schoemaker HC, van der Meer FJ, Cohen AF. Kroon C, et al. Among authors: cohen af. Circulation. 1992 Nov;86(5):1370-5. doi: 10.1161/01.cir.86.5.1370. Circulation. 1992. PMID: 1423948 Clinical Trial.

5

Effects of temazepam on saccadic eye movements: concentration-effect relationships in individual volunteers.

van Steveninck AL, Verver S, Schoemaker HC, Pieters MS, Kroon R, Breimer DD, Cohen AF. van Steveninck AL, et al. Among authors: cohen af. Clin Pharmacol Ther. 1992 Oct;52(4):402-8. doi: 10.1038/clpt.1992.162. Clin Pharmacol Ther. 1992. PMID: 1424412 Clinical Trial.

6

Pronounced effects of the combination of a new thromboxane antagonist (GR32191) and heparin on bleeding time in man.

de Boer A, Kroon JM, Kroon C, van Vliet A, Schoemaker HC, Breimer DD, Donoghue S, Cohen AF. de Boer A, et al. Among authors: cohen af. Thromb Haemost. 1992 Jul 6;68(1):24-9. Thromb Haemost. 1992. PMID: 1514168 Clinical Trial.

7

Diurnal rhythm in anticoagulant effect of heparin during a low dose constant rate infusion. A study in healthy volunteers.

Krulder JW, de Boer A, van den Besselaar AM, Cohen AF, Schoemaker HC, Briët E, Meinders AE. Krulder JW, et al. Among authors: cohen af. Thromb Haemost. 1992 Jul 6;68(1):30-2. Thromb Haemost. 1992. PMID: 1514169 Clinical Trial.

8

Self-selection for personality variables among healthy volunteers.

Pieters MS, Jennekens-Schinkel A, Schoemaker HC, Cohen AF. Pieters MS, et al. Among authors: cohen af. Br J Clin Pharmacol. 1992 Jan;33(1):101-6. doi: 10.1111/j.1365-2125.1992.tb04007.x. Br J Clin Pharmacol. 1992. PMID: 1540478 Free PMC article.

9

Intraindividual variability in nifedipine pharmacokinetics and effects in healthy subjects.

Soons PA, Schoemaker HC, Cohen AF, Breimer DD. Soons PA, et al. Among authors: cohen af. J Clin Pharmacol. 1992 Apr;32(4):324-31. doi: 10.1002/j.1552-4604.1992.tb03843.x. J Clin Pharmacol. 1992. PMID: 1569235

10

Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.

Mandema JW, Tuk B, van Steveninck AL, Breimer DD, Cohen AF, Danhof M. Mandema JW, et al. Among authors: cohen af. Clin Pharmacol Ther. 1992 Jun;51(6):715-28. doi: 10.1038/clpt.1992.84. Clin Pharmacol Ther. 1992. PMID: 1611810 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

367 results

Search Page

Filters